Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.

Ren F, Wu H, Lei Y, Zhang H, Liu R, Zhao Y, Chen X, Zeng D, Tong A, Chen L, Wei Y, Huang C.

Mol Cancer. 2010 Apr 19;9:81. doi: 10.1186/1476-4598-9-81.

2.

Experimental mouse models for hepatocellular carcinoma research.

Heindryckx F, Colle I, Van Vlierberghe H.

Int J Exp Pathol. 2009 Aug;90(4):367-86. doi: 10.1111/j.1365-2613.2009.00656.x. Review.

3.

The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.

Jiang X, Sun Q, Li H, Li K, Ren X.

Int J Cancer. 2014 Nov 1;135(9):1991-6. doi: 10.1002/ijc.28637. Epub 2013 Dec 9. Review.

4.

Translational medicine in hepatocellular carcinoma.

Gao Q, Shi Y, Wang X, Zhou J, Qiu S, Fan J.

Front Med. 2012 Jun;6(2):122-33. doi: 10.1007/s11684-012-0193-7. Epub 2012 May 9. Review.

PMID:
22573220
5.

Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies.

Liu Z, Ma Y, Yang J, Qin H.

OMICS. 2011 Jan-Feb;15(1-2):61-71. doi: 10.1089/omi.2010.0061. Epub 2010 Aug 20. Review.

PMID:
20726783
6.

Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.

Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E.

Br J Cancer. 2015 Mar 31;112(7):1141-56. doi: 10.1038/bjc.2015.38. Review.

7.

microRNAs in liver disease: from diagnostics to therapeutics.

Takahashi K, Yan I, Wen HJ, Patel T.

Clin Biochem. 2013 Jul;46(10-11):946-52. doi: 10.1016/j.clinbiochem.2013.01.025. Epub 2013 Feb 7. Review.

8.

Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.

Romano M, De Francesco F, Pirozzi G, Gringeri E, Boetto R, Di Domenico M, Zavan B, Ferraro GA, Cillo U.

Oncoscience. 2015 May 15;2(5):443-56. eCollection 2015. Review.

9.

Glycosylation-related Diagnostic and Therapeutic Drug Target Markers in Hepatocellular Carcinoma.

Watson ME, Diepeveen LA, Stubbs KA, Yeoh GC.

J Gastrointestin Liver Dis. 2015 Sep;24(3):349-57. doi: 10.15403/jgld.2014.1121.243.mew. Review.

Items per page

Supplemental Content

Write to the Help Desk